Conference on
Generic Medicines in India
Promulgating Growth & Access

03 September, 2015, Hotel Shivalikview, Chandigarh

About the event  | Sponsorship Details | Registration Form  | Register Online

Indian Pharma market is predominantly a branded generics market. Government of India has also its focus on boosting the growth of generics within India as well as for exports.  Soon to be launched “Jan Aashadhi” scheme is a testament to the importance of generics for public health and well being. 
 
However, there are several challenges that are faced by Generic drug manufacturing companies like quality issues and Global Marketing of Generic Drugs made in India, counterfeiting of drugs, regulatory issues, USFDA checks, Generic Drugs VS Patents, IPR Issues etc.
 
In this regard, ASSOCHAM in association with Department of Pharmaceuticals, Government of India, is organizing a Conference on “Generic Medicines in India: Promulgating Growth & Access” on September 3, 2015 at, Hotel Shivalikview, Chandigarh, with the objective to converge all the stakeholders at a common platform for reaching to the sustainable solutions.
 
Shri Anil Vij, Hon’ble Minister for Health & Family Welfare, Government of Haryana, is most likely to inagurate the conference.
 
Other confirmed speakers include:
  • Prof. K K Bhutani, Officiating Director, NIPER
  • Mr. Dinesh Dua, CEO & Director, Nectar Lifesciences Ltd
  • Shri Bhupinder Singh Bhoop, Chairperson, University Institute of Pharmaceutical Sciences, Punjab University
  • Shri Shushmul Maheshwari, Founder & CEO, RNCOS Business Consultancy Services
  • Mr. Ajay Singala, Drug Controller, Punjab
  • Mr. Sanjay Dhir, CEO & Managing Director, Zen Labs
  • Mr. Manish Sabharwal, Chief Executive R&D, Dr. Sabharwal's Manufacturing Labs Ltd
  • Shri Ashok Khanna, Chairman, State Cordination Committee, ASSOCHAM

Registration Fees: 

  • Delegate Fee: 1,500/- per delegate (10% discount for three or more persons from the same organization.)